.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Cerilliant
Cantor Fitzgerald
Argus Health
Cipla
Citi
Julphar
Dow
Healthtrust
Merck

Generated: June 23, 2017

DrugPatentWatch Database Preview

CIPRO HC Drug Profile

« Back to Dashboard

What is the patent landscape for Cipro Hc, and when can generic versions of Cipro Hc launch?

Cipro Hc is a drug marketed by Novartis Pharms Corp and is included in one NDA.

The generic ingredient in CIPRO HC is ciprofloxacin hydrochloride; hydrocortisone. There are thirty-one drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ciprofloxacin hydrochloride; hydrocortisone profile page.

Summary for Tradename: CIPRO HC

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list3
Clinical Trials: see list20
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CIPRO HC at DailyMed

Pharmacology for Tradename: CIPRO HC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharms Corp
CIPRO HC
ciprofloxacin hydrochloride; hydrocortisone
SUSPENSION/DROPS;OTIC020805-001Feb 10, 1998RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: CIPRO HC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis Pharms Corp
CIPRO HC
ciprofloxacin hydrochloride; hydrocortisone
SUSPENSION/DROPS;OTIC020805-001Feb 10, 19985,965,549► Subscribe
Novartis Pharms Corp
CIPRO HC
ciprofloxacin hydrochloride; hydrocortisone
SUSPENSION/DROPS;OTIC020805-001Feb 10, 19984,670,444*PED► Subscribe
Novartis Pharms Corp
CIPRO HC
ciprofloxacin hydrochloride; hydrocortisone
SUSPENSION/DROPS;OTIC020805-001Feb 10, 19985,843,930► Subscribe
Novartis Pharms Corp
CIPRO HC
ciprofloxacin hydrochloride; hydrocortisone
SUSPENSION/DROPS;OTIC020805-001Feb 10, 19984,844,902*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Teva
Covington
Chinese Patent Office
Express Scripts
Federal Trade Commission
Dow
US Department of Justice
Cipla
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot